Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- Check6 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; Back to Top element removed. No substantive content changes.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check20 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional drug information related to avelumab and axitinib. Notably, the total number of study locations has been revised from 272 to 270.SummaryDifference21%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check49 days agoChange DetectedThe web page has been updated to reflect a new total of 272 study locations, with significant additions of specific healthcare institutions and locations, including St. Vincent Healthcare and Intermountain Health St. Vincent Regional Hospital. Additionally, there are detailed updates regarding treatment metrics and definitions related to patient outcomes.SummaryDifference15%
Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.